Exact Mass: 371.0471226

Exact Mass Matches: 371.0471226

Found 18 metabolites which its exact mass value is equals to given mass value 371.0471226, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Sipatrigine

4-Amino-2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)pyrimidine

C15H16Cl3N5 (371.0471226)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D049990 - Membrane Transport Modulators D020011 - Protective Agents

   

S-sulfinatoglutathione

glutathione S-sulfinate

C10H17N3O8S2 (371.0457042)


   

Carboplatin

7,7-diamino-6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione

C6H12N2O4Pt (371.0444882)


Carboplatin is only found in individuals that have used or taken this drug. It is an organoplatinum compound that possesses antineoplastic activity. [PubChem]Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations. D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent > C1450 - Platinum Compound D000970 - Antineoplastic Agents

   
   
   
   

TERT-BUTYL 4-((4-BROMOPHENYL)THIO)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL 4-((4-BROMOPHENYL)THIO)PIPERIDINE-1-CARBOXYLATE

C16H22BrNO2S (371.05545320000004)


   

(-)-2β-Carbomethoxy-3β-(4-iodophenyl)nortropane

(-)-2β-Carbomethoxy-3β-(4-iodophenyl)nortropane

C15H18INO2 (371.0382238)


   

N-(2-Benzoyl-4-chlorophenyl)-3,4-difluorobenzamide

N-(2-Benzoyl-4-chlorophenyl)-3,4-difluorobenzamide

C20H12ClF2NO2 (371.05245859999997)


   

Denotivir

Denotivir

C18H14ClN3O2S (371.04952140000006)


C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

N-[4-[[[[oxo(thiophen-2-yl)methyl]amino]-sulfanylidenemethyl]amino]phenyl]-2-furancarboxamide

N-[4-[[[[oxo(thiophen-2-yl)methyl]amino]-sulfanylidenemethyl]amino]phenyl]-2-furancarboxamide

C17H13N3O3S2 (371.03983080000006)


   

Paraplatin

Carboplatin

C6H12N2O4Pt (371.0444882)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XA - Platinum compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents D000970 - Antineoplastic Agents

   

7-Benzoyl-3-chloroindolizine-1,2-dicarboxylic acid dimethyl ester

7-Benzoyl-3-chloroindolizine-1,2-dicarboxylic acid dimethyl ester

C19H14ClNO5 (371.05604640000007)


   

2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine

2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine

C17H19Cl2NO2S (371.05134940000005)


   

1-(2-Methoxyethyl)-7-thiophen-2-yl-5-(trifluoromethyl)pyrido[2,3-d]pyrimidine-2,4-dione

1-(2-Methoxyethyl)-7-thiophen-2-yl-5-(trifluoromethyl)pyrido[2,3-d]pyrimidine-2,4-dione

C15H12F3N3O3S (371.0551438)


   

N-(5-(3-Methoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-YL)-isonicotinamide

N-(5-(3-Methoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-YL)-isonicotinamide

C17H13N3O3S2 (371.03983080000006)


   
   

BW619c89

Sipatrigine

C15H16Cl3N5 (371.0471226)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D049990 - Membrane Transport Modulators D020011 - Protective Agents